Decentralized clinical trials can help speed execution for specific processes, yet the addition of multiple eClinical applications makes it difficult to run trials efficiently.
Pharmaceutical companies, biotechs, and CROs are rethinking their trial strategies and moving beyond decentralization for a more connected digital trial model.
Read this eBook for insights to advance toward digitally connected operations and Bayer’s steps for seamless data exchange.
See how LEO Pharma is advancing its clinical trials to deliver a better patient experience and speed the development of innovative treatments.